Belviq (Eisai Inc.)
Welcome to the PulseAid listing for the Belviq drug offered from Eisai Inc.. This Serotonin-2c Receptor Agonist [EPC],Serotonin 2c Receptor Agonists [MoA],Cytochrome P450 2D6 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Eisai Inc. |
| NON-PROPRIETARY NAME: | lorcaserin hydrochloride hemihydrate |
| SUBSTANCE NAME: | LORCASERIN HYDROCHLORIDE HEMIHYDRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Serotonin-2c Receptor Agonist [EPC],Serotonin 2c Receptor Agonists [MoA],Cytochrome P450 2D6 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-06-27 |
| END MARKETING DATE: | 0000-00-00 |
Belviq HUMAN PRESCRIPTION DRUG Details:
| Item Description | Belviq from Eisai Inc. |
| LABELER NAME: | Eisai Inc. |
| DEA SCHEDULE: | CIV
|
| ACTIVE STRENGTH: | 10(mg/1) |
| START MARKETING DATE: | 2012-06-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 62856-529_5bb86799-5f33-47e6-9209-3cc5963bfa58 |
| PRODUCT NDC: | 62856-529 |
| APPLICATION NUMBER: | NDA022529 |
Other LORCASERIN HYDROCHLORIDE HEMIHYDRATE Pharmaceutical Manufacturers / Labelers:
